What Spatz is calling for is a kind of truce, in which instead of engaging in a zero sum game, all the cholesterol drug makers pay for one single campaign for all their drugs, just getting patients to go in and ask their doctor for treatment.
We can now use artificial intelligence techniques to ask whether or not a treatment will work for an individual patient, not just for the average patient.